Challenges and potential solutions to meeting accrual goals in a Phase II chemoprevention trial for prostate cancer

Contemporary Clinical Trials

Volumn 33, Issue 2, 2012, Pages 279-285

  Kumar, Nagi ^a,b   Crocker, Theresa ^a   Smith, Tiffany ^a   Pow Sang, Julio ^a,b   Spiess, Philippe E ^a,b   Egan, Kathleen ^a,b   Quinn, Gwen ^a,b   Schell, Michael ^a,b   Sebti, Said ^a,b   Kazi, Aslam ^a,b   Chuang, Tian ^a,b   Salup, Raoul ^b,c   Helal, Mohamed ^b   Zagaja, Gregory ^d   Trabulsi, Edouard ^e   McLarty, Jerry ^f   Fazili, Tajammul ^g   Williams, Christopher R ^h   Schreiber, Fred ⁱ   Slaton, Joel ^j   Anderson, J Kyle ^j   more..

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c James A Haley VA Hospital   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

^f LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^g Overton Brooks VA   (United States)

^h UNIVERSITY OF FLORIDA   (United States)

ⁱ Watson Clinic   (United States)

^j VA MEDICAL CENTER   (United States)

more..

Author keywords

Chemoprevention trials; Clinical trials; Green tea polyphenols; Prostate cancer; Recruitment; Screening; Trial accrual

Indexed keywords

POLYPHENON E;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PATIENT; CANCER SCREENING; CHEMOPROPHYLAXIS; CLINICAL PROTOCOL; CONTROLLED STUDY; HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PROSTATE ATYPICAL SMALL ACINAR PROLIFERATION CANCER; PROSTATE CANCER; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BIOPSY; CHEMOPREVENTION; DIAGNOSIS, DIFFERENTIAL; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84856233955     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2011.11.004     Document Type: Article

References (19)

1. (accessed 9/26/11). http://www.cancer.org/Cancer/ProstateCancer/DetailedGuide/prostate-cancer-key-statistics.
2. Kelloff G.J., Lieberman R., Steele V.E., Boone C.W., Lubet R.A., Kopelovitch L., et al. Chemoprevention of prostate cancer: concepts and strategies. Eur Urol 1999, 35:342.
3. Bostwick D.G., Burke H.B., Djakiew D., Euling S., Ho S.M., Landolph J., et al. Human prostate cancer risk factors. Cancer 2004, 101:2371.
4. Mohamed M.A., Greif P.A., Diamond J., Sharaf O., Maxwell P., Montironi R., et al. Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. BJU Int 2007, 99:908.
5. Bostwick D.G., Qian J. High-grade prostatic intraepithelial neoplasia. Mod Pathol 2004, 17:360.
6. Chlebowski R.T., Menon R., Chaisanguanthum R.M., Jackson D.M. Prospective evaluation of two recruitment strategies for a randomized controlled cancer preventiontrial. Clin Trials 2010, 7(6):744-748.
7. Menon U., Gentry-Maharaj A., Ryan A., Sharma A., Burnell M., Hallett R., et al. Recruitment to multicentre trails-lessons from UKCTOCS: descriptive study. BMJ 2008, 337:12079.
8. Kye S.H., Tashkin D.P., Roth M.D., Adams B., Nie W.X., Mao J.T. Recuritment strategies for a lung cancer chemoprevention trial involving ex-smokers. Contemp Clin Trials 2009, 30(5):464-472.
9. Kumar N.B., Besterman-Dahan K., Kang L., Pow-Sang J., Xu P., Allen K., et al. Results of a randomized clinical trial of the action of several doses of lycopene in localized prostate cancer: administration prior to radical prostatectomy. Clin Med Urol Apr 16 2008, 1:1-14.
10. Kumar N.B., Krischer J.P., Allen K., Riccardi D., Besterman-Dahan K., Salup R., et al. A Phase II randomized, placebo-controlled clinical trial of purified isoflavones in modulating steroid hormones in men diagnosed with prostate cancer. Nutr Cancer 2007, 59(2):163-168.
11. Maslin-Prothero S. The role of the multidisciplinary team in recruiting to cancer clinical trials. Eur J Cancer Care 2006, 15(2):146-154.
12. Whittle J., Fletcher K.E., Morzinski J., Ertl K., Patterson L., Jensen W., et al. Ethical challenges in a randomized controlled trial of peer education among veterans service organizations. J Empir Res Hum Res Ethics 2010, 5(4):43-51.
13. Simon C., Mosavel M. Community members as recruiters of human subjects: ethical considerations. Am J Bioeth 2010, 10(3):3-11.
14. McIntosh S., Ossip-Klein D.J., Spada J., Burton K. Recruitment strategies and success in a multi-county smoking cessation study. Nicotine Tob Res 2000, 2(3):281-284.
15. Evans D.G., Harvie M., Bundred N., Howell A. Update of breast cancer prevention and screening trials. J Med Genet 2010, 47(12):853-855.
16. Embi P.J., Jain A., Harris C.M. Physicians' perceptions of an electronic health record-based clinical trial alert approach to subject recruitment: a survey. BMC Med Inform Decis Mak 2008, 8:13.
17. Gren L., Broski K., Childes J., Cordes J., Engelhard D., Gahagan B., et al. Recruitment methods employed in the prostate, lung, colorectal, and ovarian cancer screening trial. Clin Trials 2009, 6(1):52-59.
18. Mannel R.S., Walker J.L., Gould N., Scribner D.R., Kamelle S., Tillmanns T., et al. Impact of individual physicians on enrollment of patients into clinical trials. Am J Clin Oncol 2003, 26(2):171-173.
19. Heinemann S., Thüring S., Wedeken S., Schäfer T., Scheidt-Nave C., Ketterer M., et al. A clinical trial alert tool to recruit large patient samples and assess selection bias in general practice research. BMC Med Res Methodol Feb 15 2011, 11(1):16.